MT-2 (Melanotan 2 Acetate)
Overview: Melanotan 2 (MT-2) is a cyclic analog of α-melanocyte–stimulating hormone (α-MSH). It is a non-selective melanocortin receptor agonist studied for its interactions with:
- MC1R
- MC3R
- MC4R
These receptors participate in pigmentation biology, energy balance, and central melanocortin pathways.
Formulation: Lyophilized peptide powder for laboratory research
Regulatory Status: Not FDA-approved for any medical, diagnostic, or therapeutic use.
Mechanistic Notes (Research Context Only)Pigmentation PathwaysMT-2 activates MC1R in melanocytes, which is studied for its role in:
- Eumelanin production
- UV-independent pigmentation models
Central Melanocortin SignalingBecause MT-2 can cross the blood–brain barrier, studies show it interacts with MC4R, a receptor involved in:
- Appetite regulation pathways
- Energy balance signaling
- Behavioral and neuroendocrine melanocortin networks
Peripheral EffectsResearch explores its influence on:
- Insulin and glucose-related signaling pathways
- Metabolic markers
- Body composition models in preclinical systems
-
Structure–Function RelationshipMT-2 is a precursor molecule from which bremelanotide (PT-141) was derived, the only FDA-approved melanocortin analog for sexual-health indications.
MT-2 itself, however, remains research-only.